The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Sandberg, Dale M., Pillay, Anban and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. Social Science & Medicine. ISSN 0277-9536

Text (The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period) - Published Version Available under License Creative Commons Attribution. Download (935kB)

• Author
• Author

Abstract

Objective: We investigated the South African tendering system for medicines to (a) evaluate its impact on prices and market concentration over a 14-year period and (b) analyze the accuracy of government forecasts of drug demand. Methods: We calculated Herfindahl-Hirschman indexes to measure market concentration levels based on all pharmaceutical tender contracts issued by the South African government between 2003 and 2016 (n = 8,701). We estimated price indexes to track changes in medicine costs over this period. We compared prices set through tenders in the public health care system to the corresponding prices in the private system. We also analyzed government data on procurement in selected drug classes to assess the accuracy of demand forecasts. Findings: Between 2003 and 2016, the prices of medicines in most tender categories in the public health care system dropped by around 40% or more. The prices of medicines procured for the public system through tenders were almost always lower than those sold in the private system. Tenders generally remained moderately to highly competitive over time (i.e., Herfindahl-Hirschman indexes < 2,500), although the number of different firms winning contracts decreased in many categories. There were large discrepancies between the drug need estimates by the government and the quantities it went on to procure, with estimates off by more than 50% in most drug classes (9/16 observations). Conclusion: Tendering may be an effective measure to lower drug costs. Because most tenders remained competitive over time, price decreases may be durable. South African government officials should monitor the availability and prices of medicines to ensure continued access to affordable medicines for patients, as it may be undermined by the decreasing number of firms winning contracts over time. Given the large discrepancy between forecasts and procurements, the government would benefit from improving the accuracy of its demand forecasts.

Item Type:	Article
Official URL:	https://www.journals.elsevier.com/social-science-a...
Additional Information:	© 2018 The Authors
Divisions:	Health Policy
Subjects:	H Social Sciences > H Social Sciences (General) H Social Sciences > HC Economic History and Conditions H Social Sciences > HJ Public Finance J Political Science > JF Political institutions (General)
JEL classification:	I - Health, Education, and Welfare > I1 - Health > I11 - Analysis of Health Care Markets I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy; Regulation; Public Health
Date Deposited:	27 Nov 2018 15:39
Last Modified:	26 Oct 2024 23:30
Funders:	LSE Ph.D. Mobility Bursary
URI:	http://eprints.lse.ac.uk/id/eprint/90828

Actions (login required)

View Item